ArticleCardiovascular toxicology2025
Substrain-Dependent Differences in Doxorubicin-Induced Cardiotoxicity in Adult C57BL/6 Mice.
Article in Cardiovascular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Psychosocial stress exacerbates doxorubicin-induced cardiotoxicity in adult C57BL/6N mice.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Doxorubicin (DOX)-induced cardiotoxicity is widely studied using C57BL/6 mice. However, potential substrain differences between C57BL/6J (6J) and C57BL/6N (6N) remain unexamined. Comparative studies are needed to improve preclinical reproducibility and translation. Fifteen-week-old male 6N and 6J mice received either DOX (8 mg/kg/week for 3 weeks) or saline. Body weight was monitored weekly, followed by echocardiography to assess cardiac function. Histopathology evaluated cardiac fibrosis, and bulk RNA sequencing identified differentially expressed genes, which were then validated by qPCR. DOX caused significant weight loss in 6N constituted by loss of both fat and fat-free mass, while 6J showed subtle changes. Echocardiography showed a significant ejection fraction decline only in 6J, while cardiac output, stroke volume, and heart weight were reduced in both. Gene expression analysis revealed significant upregulation of atrial natriuretic peptide and myosin heavy chains in both substrains, with B-type natriuretic peptide upregulation in 6N only. Transcriptomic analysis identified 518 upregulated and 203 downregulated genes in 6N, and 406 upregulated and 445 downregulated genes in 6J, with 113 and 115 commonly upregulated and downregulated genes, respectively. Gene set enrichment analysis revealed that DOX-treated 6N mice showed enrichment of TGF-beta signaling pathways, and suppression of IL-6–JAK–STAT3, epithelial-mesenchymal transition, and myogenesis pathways. In contrast, 6J exhibited enrichment of oxidative phosphorylation, p53 pathway, and reactive oxygen species pathways. Both substrains showed enrichment of apoptosis, unfolded protein response, TNFα signaling via NF-κB, and heme metabolism pathways and downregulation of Hedgehog Signaling and Interferon Gamma Response pathways. This study demonstrates substrain-dependent differences in DOX-induced cardiotoxicity, highlighting how genetic background affects cardiac function, gene expression, and pathway enrichment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.